Oral availability of cefadroxil depends on ABCC3 and ABCC4.

Drug metabolism and disposition: the biological fate of chemicals 20120301

Cefpodoxime vs ciprofloxacin for short-course treatment of acute uncomplicated cystitis: a randomized trial.

JAMA 20120208

Extended-spectrum beta-lactamase-mediated resistance among bacterial isolates recovered from ocular infections.

Ophthalmic research 20120101

Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).

PLoS computational biology 20111201

An efficient one-pot reaction for selective fluorimetric determination of cefpodoxime and its prodrug.

Talanta 20110930

Quantitative determination of cefetamet in human plasma by liquid chromatography-mass spectrometry.

Biomedical chromatography : BMC 20110701

Cefpodoxime 10 μg disc screening test for detection of Neisseria gonorrhoeae with mosaic PBP2 and decreased susceptibility to extended-spectrum cephalosporins for public health purposes.

APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 20110601

Pharmacokinetics of cefpodoxime in plasma and subcutaneous fluid following oral administration of cefpodoxime proxetil in male beagle dogs.

Journal of veterinary pharmacology and therapeutics 20110401

[Comparison of oxacillin, cefoxitin, ceftizoxime, and moxalactam disk diffusion methods for detection of methicillin susceptibility in staphylococci].

Mikrobiyoloji bulteni 20110401

Synergistic effect of ultrasound and antibiotics against Chlamydia trachomatis-infected human epithelial cells in vitro.

Ultrasonics sonochemistry 20110101

Is ceftizoxime an appropriate surrogate for amikacin in neonatal sepsis treatment? A randomized clinical trial.

Acta medica Iranica 20110101

Pharmacokinetics, protein binding, and tissue distribution of orally administered cefpodoxime proxetil and cephalexin in dogs.

American journal of veterinary research 20101201

Enhancement of bioavailability of cefpodoxime proxetil using different polymeric microparticles.

AAPS PharmSciTech 20100901

What is your diagnosis? Emphysematous cystitis.

Journal of the American Veterinary Medical Association 20100715

Physicochemical and pharmacokinetic characterization of a spray-dried cefpodoxime proxetil nanosuspension.

Chemical & pharmaceutical bulletin 20100701

A novel sensor for cephalosporins based on electrocatalytic oxidation by poly(o-anisidine)/SDS/Ni modified carbon paste electrode.

Talanta 20100615

Cefpodoxime-induced hyperprolactinemic galactorrhea.

Annals of internal medicine 20100119

A case of immune hemolytic anemia induced by ceftizoxime and cefobactam (sulbactam/cefoperazone).

The Korean journal of laboratory medicine 20091201

Simultaneous multiresponse optimization of an HPLC method to separate seven cephalosporins in plasma and amniotic fluid: application to validation and quantification of cefepime, cefixime and cefoperazone.

Talanta 20091115

Ionic liquids as superior solvents for headspace gas chromatography of residual solvents with very low vapor pressure, relevant for pharmaceutical final dosage forms.

Journal of chromatography. A 20090807

Extended-spectrum beta-lactamase-producing phenotype signifies a poor prognosis for patients with cefpodoxime-resistant Escherichia coli or Klebsiella pneumoniae bacteremia.

Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi 20090801

Preparation of cefpodoxime proxetil fine particles using supercritical fluids.

International journal of pharmaceutics 20090318

Switch therapy in full-term neonates with presumed or proven bacterial infection.

Journal of chemotherapy (Florence, Italy) 20090201

Cephalosporins with clavulinic acid.

Indian pediatrics 20090101

Simultaneous spectrophotometric determination of Cefpodoxime proxetil and Potassium clavulanate.

Hindustan antibiotics bulletin 20090101

Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.

Journal of medicinal chemistry 20081113

Scintigraphic imaging using technetium-99m-labeled ceftizoxime in an experimental model of acute osteomyelitis in rats.

Nuclear medicine communications 20080901

In vitro study to compare sensitivity of amoxicillin+clavulanic acid and cefpodoxime+clavulanic acid among beta-lactamase positive clinical isolates of gram-positive and gram-negative pathogens.

Journal of the Indian Medical Association 20080801

Detection of extended spectrum beta-lactamase production in clinical isolates of Klebsiella spp.

The Indian journal of medical research 20080401

Gastro-retentive dosage form for improving bioavailability of Cefpodoxime proxetil in rats.

Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20080301

Preparation & characterization of solid inclusion complex of cefpodoxime proxetil with beta-cyclodextrin.

Current drug delivery 20080101

Detection of ESBL bacteria from clinical specimens: evaluation of a new selective medium.

British journal of biomedical science 20080101

Cefpodoxime proxetil compared with cefixime for treatment of typhoid fever in children.

Indian pediatrics 20071101

The comparative plasma pharmacokinetics of intravenous cefpodoxime sodium and oral cefpodoxime proxetil in beagle dogs.

Journal of veterinary pharmacology and therapeutics 20070801

Aminopenicillin-induced exanthema allows treatment with certain cephalosporins or phenoxymethyl penicillin.

The Journal of antimicrobial chemotherapy 20070701

Involvement of MRP4 (ABCC4) in the luminal efflux of ceftizoxime and cefazolin in the kidney.

Molecular pharmacology 20070601

Pharmacodynamics of simulated total versus free-drug serum concentrations of a low versus a high protein bound third-generation oral cephalosporin (Cefpodoxime versus cefditoren) against Streptococcus pneumoniae.

Journal of chemotherapy (Florence, Italy) 20070601

Inhibitors of bacterial virulence identified in a surrogate host model.

Cellular microbiology 20070501

Design and evaluation of self-nanoemulsifying drug delivery systems (SNEDDS) for cefpodoxime proxetil.

International journal of pharmaceutics 20070201

Structural identification and characterization of impurities in ceftizoxime sodium.

Journal of pharmaceutical and biomedical analysis 20070117

Simultaneous determination of cefazolin or ceftizoxime in presence of ascorbic acid from pharmaceutical formulation and human serum by RP-HPLC.

Pakistan journal of pharmaceutical sciences 20070101

[Antibiotic susceptibility of Enterobacter sakazakii isolated from powdered formula for infant and young children].

Wei sheng yan jiu = Journal of hygiene research 20070101

Cefotaxime-ciprofloxacin combination therapy for nontyphoid Salmonella bacteremia and paravertebral abscess after failure of monotherapy.

Pharmacotherapy 20061101

Application of high-performance liquid chromatography hyphenated techniques for identification of degradation products of cefpodoxime proxetil.

Journal of chromatography. A 20061006

Investigation on physicochemical and biological differences of cefpodoxime proxetil enantiomers.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20061001

Verification of cefmetazole and cefpodoxime proxetil contamination to other pharmaceuticals by liquid chromatography-tandem mass spectrometry.

Chemical & pharmaceutical bulletin 20061001

Once-daily tablet formulation and in vitro release evaluation of cefpodoxime using hydroxypropyl methylcellulose: a technical note.

AAPS PharmSciTech 20060901

Urinary tract infection caused by fluoroquinolone- and cephem-resistant Enterobacteriaceae.

International journal of antimicrobial agents 20060801

Investigation of factors responsible for low oral bioavailability of cefpodoxime proxetil.

International journal of pharmaceutics 20060724

LC/MS/MS method for the determination of trace amounts of cefmetazole and cefpodoxime proxetil contaminants in pharmaceutical manufacturing environments.

Journal of pharmaceutical and biomedical analysis 20060616

Superior discriminative performance of ceftizoxime disk diffusion test for detecting meticillin-resistant Staphylococcus aureus.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20060601

[Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2004). I. Susceptibility distribution].

The Japanese journal of antibiotics 20060601

Development and validation of isomer specific RP-HPLC method for quantification of cefpodoxime proxetil.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20060501

[Activity of cefpodoxime and other oral beta-lactams against Haemophilus influenzae and Streptococcus pneumoniae with different susceptibilities to penicillin].

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia 20060301

AmpC beta-lactamase-mediated cefpodoxime-resistant Escherichia coli isolated from faecal samples of healthy volunteers.

The Journal of antimicrobial chemotherapy 20060201

[Treatment of acute maxillary sinusitis in adults. Comparison of cefpodoxime-proxetil and amoxicillin-clavulanic acid].

Presse medicale (Paris, France : 1983) 20060101

Laboratory diagnosis of bloodstream infections caused by extended-spectrum beta-lactamase-producing E. coli and Klebsiella species.

British journal of biomedical science 20060101

Human organic anion transporter hOAT3 is a potent transporter of cephalosporin antibiotics, in comparison with hOAT1.

Biochemical pharmacology 20051001

Acidity constants of cefetamet, cefotaxime and ceftriaxone; the effect of the substituent at C3 position.

Journal of pharmaceutical and biomedical analysis 20050915

[The role of the third-generation oral cephalosporin cefditoren pivoxil in the treatment of community-acquired infection in adults].

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia 20050901

[Activity of cefpodoxime against pathogens causing respiratory, urinary or soft tissue infections].

Revista medica de Chile 20050801

Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.

Journal of pharmaceutical sciences 20050701

[Surveillance of susceptibility of clinical isolates to cefpodoxime between 2000 and 2003].

The Japanese journal of antibiotics 20050601

Tissue penetration of cefpodoxime and cefixime in healthy subjects.

Journal of clinical pharmacology 20050501

Intraoperative positive fluid balance improves tissue diffusion of ceftizoxime.

Chemotherapy 20050501

Disc diffusion-based screening tests for extended-spectrum beta-lactamases in Haemophilus influenzae.

The Journal of antimicrobial chemotherapy 20050401

Pharmacokinetic-pharmacodynamic modelling of antibacterial activity of cefpodoxime and cefixime in in vitro kinetic models.

International journal of antimicrobial agents 20050201

Rapid detection of extended-spectrum beta-lactamase (ESBL)-producing organisms in blood culture.

The Journal of antimicrobial chemotherapy 20050101

Disposition of orally administered cefpodoxime proxetil in foals and adult horses and minimum inhibitory concentration of the drug against common bacterial pathogens of horses.

American journal of veterinary research 20050101

Tissue penetration of cefpodoxime into the skeletal muscle and lung in rats.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20050101

[99mTc-ceftizoxime scintigraphy in normal rats and abscess induced rats].

Revista espanola de medicina nuclear 20050101

Cefoselis, a beta-lactam antibiotic, easily penetrates the blood-brain barrier and causes seizure independently by glutamate release.

Journal of neural transmission (Vienna, Austria : 1996) 20041201

Adsorptive properties of cefpodoxime proxetil as a tool for a new method of its determination in urine.

Journal of pharmaceutical and biomedical analysis 20041119

[Comparison of pharmacokinetics/pharmacodynamics of cefdinir, cefpodoxime proxetil and cefaclor against common bacteria of community acquired infections].

Zhonghua yi xue za zhi 20041117

The influence of pH, temperature and buffers on the degradation kinetics of cefetamet pivoxil hydrochloride in aqueous solutions.

Journal of pharmaceutical and biomedical analysis 20040903

[Epidemiological investigation of beta-lactam antibiotic induced vancomycin-resistant MRSA from clinical isolated MRSA--comparison of detection rate of BIVR with or without CZX].

Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases 20040801

Comparative evaluation of cefpodoxime versus cefixime in children with lower respiratory tract infections.

Indian journal of pediatrics 20040601

Increasing cases of drug-resistant gonorrhea prompt new CDC treatment recommendations for gay and bisexual men.

Report on medical guidelines & outcomes research 20040514

Cefpodoxime - utility in respiratory tract infections and typhoid fever.

Indian journal of pediatrics 20040501

[Treatment of functional signs of acute maxillary rhinosinusitis in adults. Efficacy and tolerance of administration of oral prednisone for 3 days].

Presse medicale (Paris, France : 1983) 20040313

Improved method of detection of beta-lactam antibiotic-induced VCM-resistant MRSA (BIVR).

International journal of antimicrobial agents 20040301

[Diagnosis of bone infection with 99mTc-ceftizoxime].

Revista espanola de medicina nuclear 20040101

Esters of cephalosporins part IX. New method of isolation of cefetamet pivoxil.

Acta poloniae pharmaceutica 20040101

Efficacy of cefpodoxime in the prophylaxis of recurrent pharyngotonsillitis.

International journal of pediatric otorhinolaryngology 20031201

[Lyme carditis and symptomatic sinus node dysfunction].

Zeitschrift fur Kardiologie 20031201

Improvement of cefpodoxime proxetil oral absorption in rats by an oil-in-water submicron emulsion.

International journal of pharmaceutics 20030916

Adsorptive stripping voltammetric determination of cefetamet in human urine.

Journal of pharmaceutical and biomedical analysis 20030808

Two-component system VraSR positively modulates the regulation of cell-wall biosynthesis pathway in Staphylococcus aureus.

Molecular microbiology 20030801

A multicentric study to evaluate efficacy and safety of cefetamet pivoxyl in lower respiratory tract infections in Indian patients.

Journal of the Indian Medical Association 20030701

[Susceptibility of major pathogens of acute pharyngitis and tonsillitis to levofloxacin and other oral antimicrobial drugs].

The Japanese journal of antibiotics 20030601

An improved method for preparation of cefpodoxime proxetil.

Farmaco (Societa chimica italiana : 1989) 20030501

Recurrent colitis with different causes.

Journal of the American Geriatrics Society 20030501

Voltammetric behavior of cefixime and cefpodoxime proxetil and determination in pharmaceutical formulations and urine.

Journal of pharmaceutical and biomedical analysis 20030326

Cefpodoxime: pharmacokinetics and therapeutic uses.

Indian journal of pediatrics 20030301

An outbreak of a CTX-M-type beta-lactamase-producing Klebsiella pneumoniae: the importance of using cefpodoxime to detect extended-spectrum beta-lactamases.

The Journal of antimicrobial chemotherapy 20030101

Kinetics of degradation of cefetamet pivaloyloxymethyl ester and its hydrochloride in solid phase.

Acta poloniae pharmaceutica 20030101

Intracerebroventricular injection of the antibiotic cefoselis produces convulsion in mice via inhibition of GABA receptors.

Pharmacology, biochemistry, and behavior 20021201

[Antibacterial activity of cefpodoxime against clinical isolates in 2000 and 2001].

The Japanese journal of antibiotics 20021201

Cefditoren pivoxil versus cefpodoxime proxetil for community-acquired pneumonia: results of a multicenter, prospective, randomized, double-blind study.

Clinical therapeutics 20021101

LC method for the analysis of cefetamet pivoxil hydrochloride in drug substance and powder for oral suspension.

Journal of pharmaceutical and biomedical analysis 20021015

Antimicrobial susceptibility of major pathogens of orofacial odontogenic infections to 11 beta-lactam antibiotics.

Oral microbiology and immunology 20021001

Third-generation cephalosporins for upper respiratory tract infections.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 20021001

Cefcapene inactivates chromosome-encoded class C beta-lactamases.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20020901

Spinal epidural abscess successfully treated with percutaneous, computed tomography-guided, needle aspiration and parenteral antibiotic therapy: case report and review of the literature.

Neurosurgery 20020801

Antibacterial activity of oral antibiotics against community-acquired respiratory pathogens from three European countries.

The Journal of antimicrobial chemotherapy 20020701

Interstitial tissue concentrations of cefpodoxime.

The Journal of antimicrobial chemotherapy 20020701

Clinical efficacy of cefpodoxime in respiratory tract infection.

The Journal of antimicrobial chemotherapy 20020701

Frequency of Pseudomonas aeruginosa serotypes in burn wound infections and their resistance to antibiotics.

Burns : journal of the International Society for Burn Injuries 20020601

[Bacterial infections of the respiratory tract and of the ENT area. Cephalosporin in general practice is effective].

MMW Fortschritte der Medizin 20020328

The excretion of cephem antibiotics into saliva is inversely associated with their plasma protein-binding activities.

Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 20020201

The beta-lactam antibiotics, penicillin-G and cefoselis have different mechanisms and sites of action at GABA(A) receptors.

British journal of pharmacology 20020101

Evaluation of probucol as suppressor of ceftizoxime induced lipid peroxidation.

Acta poloniae pharmaceutica 20020101

Linezolid versus ceftriaxone/cefpodoxime in patients hospitalized for the treatment of Streptococcus pneumoniae pneumonia.

Scandinavian journal of infectious diseases 20020101

[Observational study of the tolerance and effectiveness of cefpodoxim-proxetil in general practice].

Fortschritte der Medizin. Originalien 20020101

Transporter-mediated Drug Interactions.

Drug metabolism and pharmacokinetics 20020101

[Activity of different antimicrobial agents against penicillin-resistant Streptococcus pneumoniae].

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia 20011201

Effects of antibiotics on reactive oxygen species generation by neutrophils.

Bulletin of experimental biology and medicine 20011201

AS-924, a novel, orally active, bifunctional prodrug of ceftizoxime: physicochemical properties, oral absorption in animals, and antibacterial activity.